Marcus Zervos

Active 1986–2024

111
Papers
18,995
Citations
80
h-index
110
i10-index

Citations

Citations per year for Marcus Zervos1961: 2 citations1980: 1 citations1984: 1 citations1986: 1 citations1987: 6 citations1988: 5 citations1989: 13 citations1990: 21 citations1991: 14 citations1992: 17 citations1993: 31 citations1994: 34 citations1995: 55 citations1996: 61 citations1997: 59 citations1998: 60 citations1999: 97 citations2000: 83 citations2001: 98 citations2002: 77 citations2003: 131 citations2004: 116 citations2005: 110 citations2006: 92 citations2007: 129 citations2008: 88 citations2009: 91 citations2010: 102 citations2011: 93 citations2012: 120 citations2013: 116 citations2014: 122 citations2015: 92 citations2016: 76 citations2017: 78 citations2018: 71 citations2019: 305 citations2020: 592 citations2021: 621 citations2022: 438 citations2023: 272 citations2024: 424 citations2025: 165 citations2026: 3 citations1962–1979: no citations, so these years are not shown1981–1983: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,135 citing papers, 31.9% of this breakdownUnited Kingdom: 400 citing papers, 6% of this breakdownChina: 294 citing papers, 4.4% of this breakdownCanada: 250 citing papers, 3.7% of this breakdownItaly: 238 citing papers, 3.6% of this breakdownGermany: 236 citing papers, 3.5% of this breakdownSpain: 234 citing papers, 3.5% of this breakdownFrance: 227 citing papers, 3.4% of this breakdownAustralia: 196 citing papers, 2.9% of this breakdownIndia: 168 citing papers, 2.5% of this breakdownNetherlands: 149 citing papers, 2.2% of this breakdownSwitzerland: 135 citing papers, 2% of this breakdown
0%31.9%Other 30.4%

Fields

  • Medicine68.8%
  • Biochemistry, Genetics and Molecular Biology10.7%
  • Immunology and Microbiology7.9%
  • Psychology2.8%
  • Environmental Science2.7%
  • Agricultural and Biological Sciences2.2%
  • Other4.9%

Topics

  • Antimicrobial Resistance in Staphylococcus10.8%
  • Bacterial Identification and Susceptibility Testing5.9%
  • COVID-19 Clinical Research Studies4.7%
  • Antibiotic Resistance in Bacteria4.3%
  • SARS-CoV-2 and COVID-19 Research3.5%
  • Antifungal resistance and susceptibility2.8%
  • Other68%

Coauthors

All papers

Open in search
  1. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shu Han, Brett Leav, Deb Manzo, Rolando Pajón, F. Schödel, Joanne E. Tomassini, Honghong Zhou, Jacqueline M. Miller - New England Journal of Medicine 2021 cited by 658

  2. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

    Authors: , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2019 cited by 193

  3. Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly Hautzinger, Bethany Girard, Karen Slobod, Roderick McPhee, Rolando Pajón, Anne Aunins, Rituparna Das, Jacqueline M. Miller, Sabine Schnyder Ghamloush - New England Journal of Medicine 2022 cited by 141

  4. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 1,463

  5. Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 124

  6. Health Care–Acquired Infections in Low- and Middle-Income Countries and the Role of Infection Prevention and Control

    Authors: , - Infectious Disease Clinics of North America 2021 cited by 117

  7. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings

    Authors: , , , , , , , , , , , , , , - International Journal of Infectious Diseases 2021 cited by 256

  8. Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

    Authors: , , , , - Open Forum Infectious Diseases 2019 cited by 217

  9. Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)

    Authors: , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2024 cited by 48

  10. Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Open Forum Infectious Diseases 2021 cited by 47

  11. The Mental Health of Transgender Youth: Advances in Understanding

    Authors: , , , , - Journal of Adolescent Health 2016 cited by 682

  12. Pertussis: Microbiology, Disease, Treatment, and Prevention

    Authors: , , , - Clinical Microbiology Reviews 2016 cited by 439

  13. Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments

    Authors: , , , , , , , , , , , , - Open Forum Infectious Diseases 2019 cited by 90

  14. Vancomycin-Resistant Enterococci

    Authors: , , - Infectious Disease Clinics of North America 2021 cited by 54

  15. Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2013 cited by 346

  16. Major Variation in MICs of Tigecycline in Gram-Negative Bacilli as a Function of Testing Method

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Microbiology 2014 cited by 84

  17. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

    Authors: , , , , , , , , , , , , , , , , , - JAMA Network Open 2020 cited by 742

  18. Multiplex PCR for Detection of Aminoglycoside Resistance Genes in Enterococci

    Authors: , , , , , - Antimicrobial Agents and Chemotherapy 2003 cited by 258

  19. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study

    Authors: , , , , , , , , , - The Lancet Infectious Diseases 2011 cited by 236

  20. Vancomycin-Resistant Enterococci

    Authors: , , - Infectious Disease Clinics of North America 2016 cited by 131

  21. Dalbavancin: a novel antimicrobial

    Authors: , , - International Journal of Clinical Practice 2007 cited by 116

  22. Trends in US Hospital Admissions for Skin and Soft Tissue Infections

    Authors: , , , , , , , , - Emerging infectious diseases 2009 cited by 327

  23. Feasibility Study of the World Health Organization Health Care Facility-Based Antimicrobial Stewardship Toolkit for Low- and Middle-Income Countries

    Authors: , , , , , , , , , , , , , - Antibiotics 2020 cited by 32

  24. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas Yared, Erica Herc, Johnathan Williams, Odaliz Abreu Lanfranco, Pallavi Bhargava, Katherine Reyes - International Journal of Infectious Diseases 2020 cited by 566